aldosterone has been researched along with Abetalipoproteinemia in 1 studies
Abetalipoproteinemia: An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Illingworth, DR | 1 |
| Kenny, TA | 1 |
| Connor, WE | 1 |
| Orwoll, ES | 1 |
1 other study available for aldosterone and Abetalipoproteinemia
| Article | Year |
|---|---|
Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Abetalipoproteinemia; Adrenal Cortex; Adrenal Cortex Hor | 1982 |